Thalidomide
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Thalidomide can directly inhibit angiogenesis induced by bFGF or VEGF in vivo. |
---|
Catalog Num | A10924 |
---|---|
Formula | C13H10N2O4 |
Molecular Weight | 258.23 |
CAS Number | 50-35-1 |
SMILES | C1CC(=O)NC(=O)C1N2C(=O)C3=CC=CC=C3C2=O |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | 48 mg/mL (185.87 mM) | |
Water | Insoluble | ||
Ethanol | 2 mg/mL (7.74 mM) | ||
In vivo | 5% DMSO+30% PEG 300+1% Tween 80+ddH2O (suspension) | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 38.73 mL | 193.63 mL | 387.25 mL |
0.5 mM | 7.75 mL | 38.73 mL | 77.45 mL |
1 mM | 3.87 mL | 19.36 mL | 38.73 mL |
5 mM | 0.77 mL | 3.87 mL | 7.75 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2